What You Should Know
NVIDIA has released an open-source, GPU-accelerated Medical Physics Simulation framework as part of NVIDIA Isaac for Healthcare to model anatomy-device interactions and accelerate medical robotics development.By running 8,192 parallel simulation environments natively on GPUs, the platform reduces robotic policy training times from over five hours down to under two minutes.The framework combines classical physics (friction, contact, rigid/flexible mechanics via NVIDIA Warp
Read More
NVIDIA
NVIDIA and Persistent Systems Partner to Bring ‘Agentic AI’ to Drug Discovery
What You Should Know
The Partnership: Persistent Systems, a global digital engineering firm, is collaborating with NVIDIA to deploy AI-powered solutions specifically for the Healthcare and Life Sciences (HLS) sector.The Goal: The collaboration aims to move BioPharma companies out of the "AI experimentation" phase and into real-world, production-grade deployments for computational drug discovery and research.The Tech Stack: Persistent is utilizing the full-stack NVIDIA AI platform, including
Read More
Aidoc Partners with NVIDIA MONAI to Scale Open-Source Clinical AI
What You Should Know:
- Aidoc, a leader in clinical AI, has expanded its aiOS™ (AI Operating System) through a collaboration with NVIDIA MONAI and a new partnership with Quibim to solve the "last mile" deployment challenge for imaging AI.
- The ecosystem expansion allows health systems to rapidly and reliably deploy internally developed and open-source models built on MONAI directly into routine clinical workflows at scale. The move validates the need for a unified operating system
Read More
Living Optics and NVIDIA Jetson Showcase Real-Time Hyperspectral Imaging
What You Should Know:
- Living Optics, a leader in hyperspectral imaging (HSI), has announced its latest real-time blood perfusion demonstration, which was built on the NVIDIA Jetson platform. The demonstration offers a glimpse into the future of edge AI for healthcare, life sciences, and precision imaging.
- The live demo showcases how the company’s spectral vision technology can distinguish between oxygenated and deoxygenated blood in real-time. This capability provides critical
Read More
NVIDIA Introduces La-Proteina: A Breakthrough in Atomistic Protein Generation via Partially Latent Flow Matching
What You Should Know:
- NVIDIA Research, in collaboration with the University of Oxford and Mila – Québec AI Institute, has unveiled La-Proteina, a novel method for atomistic protein design.
- Published on arXiv on July 13, 2025, La-Proteina is designed to directly generate fully atomistic protein structures jointly with their underlying amino acid sequences, addressing a critical challenge in de novo protein design.
Optimizing Protein Design with Fixed-Dimensional Latent
Read More
Researchers Develop AI Model to Detect Malaria Using NVIDIA
What You Should Know:
- A team of researchers at the intersection of medicine and technology has harnessed the power of artificial intelligence (AI) and NVIDIA GPUs to develop a new AI solution.
- Their recent publication in the prestigious journal Nature details the creation of a sophisticated convolutional neural network (CNN) specifically designed for the automated detection of malaria parasites in blood samples.
Venezuela's Malaria Resurgence
While the glint of gold has
Read More
GE HealthCare & NVIDIA to Develop Autonomous Diagnostic Imaging with AI
What You Should Know:
- At GTC 2025, GE HealthCare and NVIDIA announced an expanded collaboration aimed at revolutionizing diagnostic imaging through autonomous technologies, beginning with X-ray and ultrasound.
- The collaboration builds on a long-standing relationship between GE HealthCare and NVIDIA. A prime example of their synergy is the development of SonoSAMTrack, GE HealthCare’s pioneering research foundation model. Trained on approximately 200,000 image-mask pairs,
Read More
NVIDIA BioNeMo Framework Accelerates AI Drug Discovery
What You Should Know:
- NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.
- The framework provides a powerful suite of tools for scaling AI models in biomolecular research, bringing supercomputing capabilities to the forefront of drug development.
Accelerating Drug Discovery with AI
The BioNeMo Framework addresses the growing need
Read More
